期刊文献+

莫西沙星对224株肠球菌的体外抗菌活性研究 被引量:12

In vitro antibacterial activity of domestic moxifloxacin against 224 strains of enterococci
下载PDF
导出
摘要 目的观察莫西沙星对224株肠球菌的体外抗菌活性。方法采用二倍琼脂稀释法对224株肠球菌进行体外抗菌实验,并与意大利A ven tis公司生产的替考拉宁和L illy公司生产的万古霉素进行抗菌效果对比。结果莫西沙星的抗菌效果较好,对169株粪肠球菌和51株屎肠球菌的M IC90均为4m g/L,替考拉宁和万古霉素对169株粪肠球菌的M IC90分别为1、2m g/L;对51株屎肠球菌的M IC90分别为0.5和2m g/L。结论莫西沙星对224株肠球菌的抗菌效果较好,肠球菌对莫西沙星的敏感率均为76.34%。莫西沙星的抗菌效果低于替考拉宁和万古霉素。 Objective To investigate the in vitro antibacterial activity of moxifloxacin against 224 strains of enterococci. Methods Determination of antibacterial activity of domestic moxifloxacin against (enterococci) including 169 strains of Enterococcus faecalis, 51 strains of E.faecium, etc. was performed by using agar dilution method, with teicoplanin (Aventis) and vancomycin (Lilly) as control. Results The antibacterial efficacy of moxifloxacin against 224 strains of enterococci was good, and the MIC_(90) of moxifloxacin, (teicoplanin) and vancomycin against E.faecalis (169 strains) and E.faecium (51 strains) were 4, 1, 2, and 4, 0.5, 2mg/L respectively. Conclusion Moxifloxacin had strong antibacterial activity against 224 strains of enterococci, and the sensitive rates of enterococci to moxifloxacin, teicoplanin, and vancomycin were 75.74%, 100% and 100% respectively.
出处 《中国抗生素杂志》 CAS CSCD 北大核心 2005年第7期412-415,427,共5页 Chinese Journal of Antibiotics
关键词 莫西沙星 替考拉宁 万古霉素 肠球菌 粪肠球菌 屎肠球菌 抗菌活性 Moxifloxacin Teicoplanin Vancomycin Enterococcus E.faecalis E. faecium Antibacterial activity
  • 相关文献

参考文献17

  • 1Brueggemann A B, Kugler K C, Doern G V. In vitro activity of Bay 12-8039, a novel 8-methoxyquinolone,compared to activities of six fluoroquinolones against Streptococcus pneumoniae , Haemophilus influenzae , and Moraxella catarrhalis [J]. Antimicrob Agents Chemother,1997,41 (7): 1594
  • 2Holt J G, Krieg N R, Sneath P A. Bergey's Manual of Determinative Bacteriology [M]. 9th ed., Baltimore:Williams & Wilkins, 1994: 532
  • 3Carvalno M G S, Teixeira M L, Facklam. Use of test for acidification of methyl-α-D-glucopyranoside of Enterococcus and susceptibility to efrotomycin for differentiation of strains of Enterococcus and some related genera [J]. J Clin Microbiol, 1998,36 (6): 1584
  • 4Balows A. Manual of clinical microbiology [M]. 5th ed.Washington DC: American Society for Microbiology,1991:1105
  • 5李仲兴 郑家齐.诊断细菌学[M].香港:黄河文化出版社,1992.295-297.
  • 6Bauernfeind A. Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155),trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin [J]. J Antimicrob Chemother, 1997,40: 639
  • 7Woodcock J M, Andrews J M, Boswell F J, et al. In vitro activity of Bay 12-8039, a new fluoroquinolone [J].Antimicrob Agents Chemother, 1997,41 ( 1 ): 101
  • 8Fass R J. In vitro activity of Bay 12-8039, a new 8-methoxyquinolone [J]. Antimicrob Agents Chemother,1997,41(8) :1818
  • 9Hoogkamp-Korstanje J A A, Roelofs-Willemse J. Comparative in vitro activity of moxifloxacin against Grampositive clinical isolates [J]. J Antimicrob Chemother,2000,45:31
  • 10French G L, Enterococci and vancomycin resistance [J].Clin Infect Dis, 1998,27(Suppl 1) :S75

二级参考文献21

  • 1Dowzicky M,Nadler HL,Feber C,et al.Evaluation of in vitro activity of quinupirstin/dalfoprstin and comparator antimicrobial agents against worldwide clincal trial and other laboratory isolates[J].Am J Med,1998,104(5A) :34S
  • 2Moellering RC,Linden PK,Reinhardt J,et al.The efficacy and safety of quinupirstin/dalfoprstin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium [J].J Antimicrob Chemother,1999,44:251
  • 3Murray BE.Vancomycin-resistant enterococal infections [J].N Engl J Med ,2000,342:710
  • 4Matsumura S,Simor AE.Treatment of endocarditis due to vancomycin-resistant Enterococci faecium with quinupirstin/dalfoprstin,doxycycline,and rifampin:a synergistic drug combination[J].Clin Infect Dis,1998,27:1554
  • 5Olsen K,Rebuck J,Rupp M.Arthralgias and myalgias related to quinupirstin/dalfoprstin administration [J].Clin Infect Dis ,200 1,32:E83
  • 6Shinabarger DL,Marotti KR,Murray RW,et al.Mechanism of action of oxazolidinones:effects of linezolid and eperzolid on translation reactions [J].Antimicrob Agents Chemother,1997,41:2131
  • 7Noskin GA,Siddiqul F,Stosor V,et al.In vitro activities of linezolid agaist important gram-positive bacterial pathogens including vancomycin-resistant enterococci[J].Antimicrob Agents Chemother ,1999,43:2059
  • 8Green SL,Maddox JC,Huttenbach ED.Linezolis and reversible myelosuppression[J].JAMA,2001,285:1291
  • 9Snydman DR,Jacobus NV,McDermott LA,et al.Comparative in vitro activities of daptomycin and vancomycin against resistant gram-positive pathogens[J].Antimicrob Agents Chemother,2000,44:3447
  • 10Barry AL,Fuche PC,Brown SD.In vitro activities of daptomycin against 2,789 clinical isolates in 11 North American medical centers[J].Antimicrob Agents Chemother,2001,45:1919

共引文献267

同被引文献62

引证文献12

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部